Francis Matthew Pleta, Reigen Placido, Delfin Yñigo Pilapil, Ma Dianne Parado, Amanda Pauline Paris, Neil Joshua Patiag, Alfonzo Martin Pedro, Julia Audrey Peralta, Regis Patrick Pilar, Herdee Gloriane Luna, Warren Bacorro
{"title":"A Nationwide Survey on Knowledge, Attitudes, and Practices of Filipino Oncologists and Oncology-Related Professionals on Shared Decision Making.","authors":"Francis Matthew Pleta, Reigen Placido, Delfin Yñigo Pilapil, Ma Dianne Parado, Amanda Pauline Paris, Neil Joshua Patiag, Alfonzo Martin Pedro, Julia Audrey Peralta, Regis Patrick Pilar, Herdee Gloriane Luna, Warren Bacorro","doi":"10.1111/ajco.14178","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To explore the knowledge, attitudes, and practices of Filipino oncologists and oncology-related professionals on shared decision making (SDM), evaluate their familiarity with and use of evidence-based medicine (EBM) and clinical practice guidelines (CPG), and identify barriers and facilitators to SDM.</p><p><strong>Methods: </strong>A cross-sectional, nationwide online survey was conducted from April 1 to May 15, 2024, using voluntary response sampling.</p><p><strong>Results: </strong>87 respondents participated. Most practice in the National Capital Region (NCR) (n = 48, 55%), Luzon (outside NCR) (n = 22, 25%), Mindanao (n = 11, 13%), and Visayas (n = 8, 9%); 56 (64%) practice in both government and private centers. Most lacked a full conceptual understanding of SDM. Almost all had a positive attitude toward its implementation. 62 (71%) indicated that they share responsibility with their patients for making decisions. The top reason for not applying SDM in appropriate situations was patient deference to the clinician's decision (n = 37, 43%). Choosing among treatment options with equivalent effectiveness but different toxicity profiles (n = 86, 99%) was the most reported situation deemed appropriate for SDM. Key barriers to SDM implementation were patient-related factors, family dynamics, health financing, and time constraints. Several expressed the need for adequate time and effective communication to facilitate SDM.</p><p><strong>Conclusion: </strong>Most surveyed Filipino oncologists and oncology-related professionals reported applying SDM and had a positive attitude toward it. However, a fuller conceptual understanding of the process is lacking. Patient-, family-, and health financing-related barriers were identified. Enhancing SDM education among oncologists may improve the clinical application, and exploring the perspectives of other stakeholders may enhance its institutionalization.</p>","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Pacific journal of clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ajco.14178","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To explore the knowledge, attitudes, and practices of Filipino oncologists and oncology-related professionals on shared decision making (SDM), evaluate their familiarity with and use of evidence-based medicine (EBM) and clinical practice guidelines (CPG), and identify barriers and facilitators to SDM.
Methods: A cross-sectional, nationwide online survey was conducted from April 1 to May 15, 2024, using voluntary response sampling.
Results: 87 respondents participated. Most practice in the National Capital Region (NCR) (n = 48, 55%), Luzon (outside NCR) (n = 22, 25%), Mindanao (n = 11, 13%), and Visayas (n = 8, 9%); 56 (64%) practice in both government and private centers. Most lacked a full conceptual understanding of SDM. Almost all had a positive attitude toward its implementation. 62 (71%) indicated that they share responsibility with their patients for making decisions. The top reason for not applying SDM in appropriate situations was patient deference to the clinician's decision (n = 37, 43%). Choosing among treatment options with equivalent effectiveness but different toxicity profiles (n = 86, 99%) was the most reported situation deemed appropriate for SDM. Key barriers to SDM implementation were patient-related factors, family dynamics, health financing, and time constraints. Several expressed the need for adequate time and effective communication to facilitate SDM.
Conclusion: Most surveyed Filipino oncologists and oncology-related professionals reported applying SDM and had a positive attitude toward it. However, a fuller conceptual understanding of the process is lacking. Patient-, family-, and health financing-related barriers were identified. Enhancing SDM education among oncologists may improve the clinical application, and exploring the perspectives of other stakeholders may enhance its institutionalization.
期刊介绍:
Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.